On Wednesday, Shares of Tableau Software Inc (NYSE:DATA), lost -10.57% to $113.64.
Tableau Software, stated results for its second quarter ended June 30, 2015.
- Tableau Software logo www.tableausoftware.com.
- Total revenue grew to $149.9 million, up 65% year over year.
- License revenue grew to $96.7 million, up 60% year over year.
- International revenue grew to $36.7 million, up 83% year over year.
- Added more than 3,000 new customer accounts.
- Closed 233 transactions greater than $100,000.
- Diluted GAAP loss per share was $0.27; diluted non-GAAP earnings per share were $0.07.
“Tableau executed another strong quarter as we continue to acquire new customers, expand relationships with existing customers, grow internationally and rapidly innovate,” said Christian Chabot, Chief Executive Officer of Tableau Software. “We are seeing a strong demand for Tableau’s products resulting in record customer growth and product adoption. During the quarter we added more than 3,000 new customer accounts, bringing the total to more than 32,000 worldwide.”
Tableau Software, Inc., together with its auxiliaries, provides business analytics software products in the United States, Canada, and internationally. The company offers Tableau Desktop, a self-service analytics environment that empowers people to access and analyze data independently; and Tableau Server, a business intelligence platform with data administration, scalability, and security to foster the sharing of data, in addition to to improve the dissemination of information in an organization and promote improved decision-making.
Shares of Express Scripts Holding Company (NASDAQ:ESRX), declined -1.18% to $91.29, during its last trading session.
Express Scripts Holding Company, declared 2015 second quarter net income attributable to Express Scripts stockholders of $600.1 million, or $0.88 per diluted share. Adjusted earnings per diluted share, as detailed in Table 4, were $1.44 for the second quarter. 1
“It is clear many companies across healthcare are validating the need for size and scale,” said George Paz, Chairman and Chief Executive Officer. “But, what matters most is how that size and scale is leveraged. In our case, that means creating a business model fully aligned with client needs. By aligning our interests with those of our patients and clients our scale is focused on driving down costs while improving health outcomes. Our focused size and scale assists us make prescription drugs safer and more affordable which benefits everyone in healthcare — patients, plan sponsors and medical professionals. We are happy with our second quarter results and outperforming our guidance. Our results are a testament to our model of driving performance through our focused scale and alignment.”
Express Scripts Holding Company operates as a pharmacy benefit administration (PBM) company in the United States and Canada. The company operates through two segments, PBM and Other Business Operations.
Finally, Inphi Corporation (NYSE:IPHI), ended its last trade with 5.15% gain, and closed at $22.24.
Inphi Corporation, declared the financial results for its second quarter ended June 30, 2015.
Revenue in the second quarter of 2015 was a record $60.7 million, up 2.6% sequentially from $59.2 million stated in the first quarter of 2015 and up 79% year-over-year, contrast with $33.9 million in the second quarter of 2014.
Inphi Corporation provides high-speed analog and mixed signal semiconductor solutions for the communications, datacenter, and computing markets worldwide. Its analog and mixed signal semiconductor solutions offer high signal integrity at data speeds while reducing system power consumption.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
